[BIOSTAR PHARMACEUTICALS, RECEIVES APPROVAL FROM XIANYANG SFDA TO RESTARTLES OF ITS GELPSULE DRUGS XIANYANG, China, August 3, 2012 - Biostar Pharmaceuticals, (NASDAQ GM: BSPM) ("Biostar" or "thempany"), a-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases andnditions, today announced that on July 30, 2012, after a thorough]
[August 6, 2012 VIA EDGAR Kathleen Collins, Accounting Branch Chief Laura Veator, Staff Accountant Division of Corporation Finance 100 F Street, N.E. Re: Ctrip.com International, Ltd. (the Company) Form 20-F for the Fiscal Year Ended December 31, 2011 Filed on March 30, 2012 (the 2011 Form 20-F) (File No. 001-33853) Dear Ms. Collins and Ms. Veator: * * * Form]
[Item 1 Information Contained in this Form 6-K Report SEASPAN CORPORATION Sai W. Chu Chief Financial Officer REPORT ON FORM 6-K FOR THE QUARTER ENDED JUNE 30, 2012 INDEX PART I FINANCIAL INFORMATION 1 Item 1 Interim Consolidated Financial Statements (Unaudited) 1 Item 2 Managements Discussion and Analysis of Financial Condition and Results of Operations 25]
[Item 1 Information Contained in this Form 6-K Report SEASPAN CORPORATION Sai W. Chu Chief Financial Officer REPORT ON FORM 6-K FOR THE QUARTER ENDED JUNE 30, 2012 INDEX PART I FINANCIAL INFORMATION 1 Item 1 Interim Consolidated Financial Statements (Unaudited) 1 Item 2 Managements Discussion and Analysis of Financial Condition and Results of Operations 25]
[THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred (Incorporated in Hong Kong with limited liability under the Companies Ordinance) (Stock Code: 00883) CONNECTED TRANSACTION RELATING TO THE COALBED METHANE RESOURCES EXPLORATION AND DEVELOPMENT COOPERATION AGREEMENT Independent Financial Adviser to the Independent Board Committee SOMERLY LIMITED A notice] [(Incorporated in Hong Kong with limited liability under the Companies Ordinance) (Stock Code: 00883) NOTICE OF EXTRAORDINARY GENERAL MEETING NOTICE IS HEREBY GIVEN “ ” ORDINARY RESOLUTION “ THAT ” By Order of the Board CNOOC Limited Zhong Hua Joint Company Secretary Hong Kong, 3 August 2012 Registered Office: 65th Floor, Bank of China Tower 1 Garden Road Hong Kong] [(Incorporated in Hong Kong with limited liability under the Companies Ordinance) (Stock Code: 00883) Form of proxy for the Extraordinary General Meeting to be held on 21 August 2012 I/We (Note 1) of being the registered holder(s) of shares (Note 2) of HK$0.02 each in the share capital of the above-named Company HEREBY APPOINT THE CHAIRMAN OF THE MEETING (Note]
[THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred (Incorporated in Hong Kong with limited liability under the Companies Ordinance) (Stock Code: 00883) CONNECTED TRANSACTION RELATING TO THE COALBED METHANE RESOURCES EXPLORATION AND DEVELOPMENT COOPERATION AGREEMENT Independent Financial Adviser to the Independent Board Committee SOMERLY LIMITED A notice] [(Incorporated in Hong Kong with limited liability under the Companies Ordinance) (Stock Code: 00883) NOTICE OF EXTRAORDINARY GENERAL MEETING NOTICE IS HEREBY GIVEN “ ” ORDINARY RESOLUTION “ THAT ” By Order of the Board CNOOC Limited Zhong Hua Joint Company Secretary Hong Kong, 3 August 2012 Registered Office: 65th Floor, Bank of China Tower 1 Garden Road Hong Kong] [(Incorporated in Hong Kong with limited liability under the Companies Ordinance) (Stock Code: 00883) Form of proxy for the Extraordinary General Meeting to be held on 21 August 2012 I/We (Note 1) of being the registered holder(s) of shares (Note 2) of HK$0.02 each in the share capital of the above-named Company HEREBY APPOINT THE CHAIRMAN OF THE MEETING (Note]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer]
[Mindray Announces Second Quarter 2012 Financial Results Shenzhen, China August6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million, anrease of 23.3% over]
